{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:59:27Z","timestamp":1775102367955,"version":"3.50.1"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ebiom.2026.106149","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T12:47:14Z","timestamp":1769863634000},"page":"106149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Letter in response to \u201cKappa free light chain index as a substitute to oligoclonal bands in diagnosing multiple sclerosis\u201d"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4541-8841","authenticated-orcid":false,"given":"Florian","family":"Deisenhammer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2833-6337","authenticated-orcid":false,"given":"Harald","family":"Hegen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ebiom.2026.106149_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70291","article-title":"Kappa free light chain index correlates with prognostic biomarkers in multiple sclerosis and decreases slowly following treatment","volume":"32","author":"Duell","year":"2025","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106149_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040842","article-title":"The impact of immunomodulatory treatment on Kappa free light chains as biomarker in neuroinflammation","volume":"9","author":"Konen","year":"2020","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106149_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70355","article-title":"Kappa free light chain index in the real world-do we miss clinically relevant information by skipping oligoclonal banding?","volume":"32","author":"Hegen","year":"2025","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ebiom.2026.106149_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105984","article-title":"Vanishing clues: a systematic review of oligoclonal band disappearance in multiple sclerosis patients after treatment","volume":"92","author":"Al-Draye","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.ebiom.2026.106149_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.clinbiochem.2023.04.006","article-title":"Variation in processes and reporting of cerebrospinal fluid oligoclonal banding and associated tests and calculated indices across Canadian clinical laboratories","volume":"116","author":"Higgins","year":"2023","journal-title":"Clin Biochem"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426000307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426000307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T02:44:17Z","timestamp":1775097857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426000307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":5,"alternative-id":["S2352396426000307"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106149","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letter in response to \u201cKappa free light chain index as a substitute to oligoclonal bands in diagnosing multiple sclerosis\u201d","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106149"}}